1. 2167 Microsatellite status predicts BRAF V600E and KRAS exon 2 mutations prognostic value in stage III colon cancers (CC) patients treated with adjuvant FOLFOX +/- cetuximab. A post-hoc analysis of the PETACC8 trial. (September 2015) Authors: Taieb, J.; Zaanan, A.; Malicot, K. Le; Julie, C.; Blons, H.; Mineur, L.; Tabernero, J.; Mini, E.; Folprecht, G.; Laethem, J.L. Van; Lepage, C.; Emile, J.F.; Laurent-Puig, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 36LBA Pathological response to neoadjuvant 5-FU, oxaliplatin and docetaxel (FLOT) versus epirubicin, cisplatin and 5-FU (ECF) in patients with locally advanced, resectable gastric/esophagogastric junction (EGJ) cancer: Data from the phase II part of the FLOT4 phase III study of the AIO. Issue 3 (September 2015) Authors: Pauligk, C.; Tannapfel, A.; Meiler, J.; Luley, K.B.; Kopp, H.G.; Homann, N.; Hofheinz, R.D.; Schmalenberg, H.; Probst, S.; Haag, G.M.; Egger, M.; Behringer, D.M.; Stoehlmacher, J.; Prasnikar, N.; Block, A.; Trojan, J.; Folprecht, G.; Pohl, M.; Schirmacher, P.; Al-Batran, S.E. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FOLFIRI plus cetuximab in patients with liver-limited or non-liver-limited RAS wild-type metastatic colorectal cancer: A retrospective subgroup analysis of the CRYSTAL study. Issue 10 (October 2016) Authors: Köhne, C.-H.; Poston, G.; Folprecht, G.; Ciardiello, F.; Ronga, P.; Beier, F.; Van Cutsem, E. Journal: European journal of surgical oncology Issue: Volume 42:Issue 10(2016:Oct.) Page Start: 1540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0384 QoL after multimodal treatment of rectal cancer with/without oxaliplatin (phase 3, CAO/ARO/AIO-04). (April 2019) Authors: Kosmala, R.; Fokas, E.; Flentje, M.; Sauer, R.; Liersch, T.; Graeven, U.; Fietkau, R.; Hohenberger, W.; Arnold, D.; Hofheinz, R.; Ghadimi, M.; Raab, H.; Ströbel, P.; Staib, L.; Grabenbauer, G.G.; Folprecht, G.; Uter, W.; Gall, C.; Rödel, C.; Polat, B. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-0501 Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial. (April 2019) Authors: Fokas, E.; Allgäuer, M.; Polat, B.; Klautke, G.; Grabenbauer, G.; Fietkau, R.; Kuhnt, T.; Staib, L.; Brunner, T.; Grosu, A.L.; Schmiegel, W.; Jacobasch, L.; Weitz, J.; Folprecht, G.; Schleska-Lange, A.; Grützmann, R.; Schwarzbach, M.; Paolucci, V.; Bechstein, W.O.; Friede, T. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3. (January 2018) Authors: Modest, D.P.; Denecke, T.; Pratschke, J.; Ricard, I.; Lang, H.; Bemelmans, M.; Becker, T.; Rentsch, M.; Seehofer, D.; Bruns, C.J.; Gebauer, B.; Modest, H.I.; Held, S.; Folprecht, G.; Heinemann, V.; Neumann, U.P. Journal: European journal of cancer Issue: Volume 88(2018) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗